GL1X · GenesisL1 explorer

MolNFT v1 · #168684 · protein

Structure of hepatitis C virus envelope glycoprotein E2 core from genotype 6A bound to broadly neutralizing antibody U1

6WO3: “Structure of hepatitis C virus envelope glycoprotein E2 core from genotype 6A bound to broadly neutralizing…”. X-ray diffraction, 1 ligand (NAG), 6 pockets (best druggability 0.65). MolNFT v1 #168684 on GenesisL1: 3D structure…

PDB
6WO3
Type
protein
Length
582 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Envelope glycoprotein E2; Fab U1 heavy chain; Fab U1 light chain
Ligands
NAG
Pockets
6 · best druggability 0.65

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
EEnvelope glycoprotein E2protein14811% helix, 36% strand—
HFab U1 heavy chainprotein2238% helix, 51% strand—
LFab U1 light chainprotein2116% helix, 53% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains E, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16910.650.7561empty
21180.650.8924empty
31360.460.7727empty
41150.350.7322empty
5730.310.7413empty

Interfaces

2 interfaces between chains.

  • H–L · 1931 Ų buried · 16 hydrogen bonds · protein-protein
  • E–H · 696 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 6WO3 · Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to… · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.